Oral Bacteria and Allergic Disease in Children
NCT00438646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2009-08-25
Summary
This study will see if bacteria differ between children who have allergies or asthma and children who do not have allergies or asthma. Previous research suggests that some bacteria may protect against allergies and asthma. This study may provide more information on why some children develop allergies and asthma.
Patients at the University of North Carolina-Chapel Hill School of Dentistry who are between 6 and 11 years of age may be eligible for this study.
Parents of participating children complete a questionnaire about the child and the child's health. The child provides a saliva sample by chewing a small piece of wax and spitting in a cup.
The saliva sample is analyzed in the laboratory for bacteria, yeast and antibodies (substances the body produces to fight germs).
...
Conditions
- Asthma
- Rhinitis
- Eczema
- Respiratory Sounds
- Hypersensitivity
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Eligibility
- Min Age
- 6 Years
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2008-12-31
Countries
- United States
Study Locations
More Related Trials
-
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
NCT01537133 ·Status: COMPLETED ·Phase: NA
-
Mold Sensitization Associated Severe Asthma Exacerbation
NCT03690349 ·Status: COMPLETED
-
Airway Immune Response to Allergens (Use Lay Language Here)
NCT04619017 ·Status: UNKNOWN ·Phase: PHASE1
-
Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)
NCT00943683 ·Status: COMPLETED ·Phase: NA
-
Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia
NCT01326494 ·Status: COMPLETED ·Phase: PHASE4
-
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
NCT05113394 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Montelukast on Airway Regulatory T Cells in Asthma
NCT01951898 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children
NCT00172341 ·Status: UNKNOWN ·Phase: PHASE4
-
Children With Asthma in New Orleans After Hurricane Katrina
NCT00426634 ·Status: COMPLETED
-
Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.
NCT00200928 ·Status: COMPLETED ·Phase: NA
-
Use of DNAse in Neutrophilic Asthma
NCT03994380 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Airway Microbiota Based Treatment of Asthma in Preschool Children
NCT04527016 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Health Status of Asthmatic Children
NCT04388098 ·Status: COMPLETED
-
A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)
NCT00117338 ·Status: COMPLETED ·Phase: PHASE3
-
Inflammatory Markers in Exhaled Breath Condensates From Asthmatic Patients
NCT01246414 ·Status: COMPLETED
-
Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults
NCT00839189 ·Status: COMPLETED ·Phase: PHASE1
-
Characterising the Microbiota in Asthma
NCT02671773 ·Status: COMPLETED
-
Risk Factors For Asthma in Laboratory Animal Allergy
NCT00005283 ·Status: COMPLETED
-
Herbal Lollipops on Oral Bacterial Levels and DMFT/Dmft Scores of Children With Asthma Using Inhalers
NCT01147835 ·Status: TERMINATED ·Phase: NA
-
Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old
NCT03364959 ·Status: TERMINATED ·Phase: NA
-
Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma
NCT03615248 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mold Exposure and Impact on Asthma Control in French Asthmatic Children
NCT04918394 ·Status: COMPLETED
-
Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)
NCT00943397 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
NCT00485576 ·Status: COMPLETED ·Phase: PHASE2
-
Home Based Environmental Adherence Trial
NCT00005523 ·Status: COMPLETED